Fluticasone Propionate

Overview

Fluticasone Propionate is a synthetic glucocorticoid with anti-inflammatory and vasoconstrictive properties. It is commonly used in the treatment of respiratory disorders such as asthma and allergic rhinitis.

API suppliers (33)

Suppliers of Fluticasone Propionate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Cipla USA, Inc.USA3 active DMF
• GlaxoSmithKline plcUnited Kingdom2 active DMF
• STERLING SPAItaly1 active DMF
• TAPI NL BV1 active DMF
• WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
• Hovione FarmaCiencia SAPortugal1 active DMF
• STERLING SPAItaly1 active DMF
• TAPI NL BV1 active DMF
• WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
• Hovione FarmaCiencia SAPortugal1 active DMF
• NEWCHEM SPA1 active DMF
• STERLING SPAItaly1 active DMF
• Hovione FarmaCiencia SAPortugal1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF
• TAPI NL BV1 active DMF
• STERLING SPAItaly1 active DMF
• WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
• FARMABIOS SPA1 active DMF
• WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
• FARMABIOS SPA1 active DMF
• Ono Pharmaceutical Co., Ltd.Japan1 active DMF
• NEWCHEM SPA1 active DMF
• Hovione FarmaCiencia SAPortugal1 active DMF
• STERLING SPAItaly1 active DMF
• Ono Pharmaceutical Co., Ltd.Japan1 active DMF

Showing 25 of 33 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (25 approved US products), the latest listed US patent on Fluticasone Propionate expires 23 Feb 2036 and exclusivity 15 Mar 2027. Generic API sourcing typically opens up once these lapse.

Therapeutic areas